首页> 外文期刊>Clinical transplantation. >Comparison of methods of providing analgesia after pancreas transplant: IV opioid analgesia versus transversus abdominis plane block with liposomal bupivacaine or continuous catheter infusion
【24h】

Comparison of methods of providing analgesia after pancreas transplant: IV opioid analgesia versus transversus abdominis plane block with liposomal bupivacaine or continuous catheter infusion

机译:胰腺移植后提供镇痛方法的比较:IV阿片类镇痛与脂质体Bupivacaine或连续导管输注的横向腹腹梗阻

获取原文
获取原文并翻译 | 示例
       

摘要

Background Current practices emphasize a multimodal approach to perioperative analgesia due to higher efficacy and decreased opioid usage. Analgesia for pancreas transplant (PT) has traditionally been managed with intravenous (IV) opioids, and reports of transversus abdominis plane (TAP) blocks are limited in this population. Methods Three interventions were compared in adult PT patients, including IV opioids, TAP catheter, and TAP block with liposomal bupivacaine. Time to return of intestinal function and oral diet, postoperative pain scores, opioid usage, and length of stay were recorded. Results Study included 197 PT patients: 62 (32%) standard care, 90 (45%) TAP catheters with continuous 0.2% ropivacaine, and 45 (23%) single liposomal bupivacaine TAP block. Pain scores were lowest for the IV opioid group (P < 0.001). The liposomal bupivacaine group had lower pain scores on postoperative days (POD) 1-5 than the TAP catheter group. Opioid use during POD 1-5 was lower for both TAP block groups (P = 0.03). Time to bowel function was faster for the TAP block groups (P < 0.05). Conclusions Compared with IV opioid analgesia, TAP block interventions were associated with lower overall use of opioids and a faster time to intestinal function following pancreas transplant.
机译:背景技术由于更高的疗效和表阿片类药物,强调围手术期镇痛的多模式方法。对胰腺移植(PT)的镇痛传统上与静脉内(IV)阿片类药物进行管理,并且对该群体的横向腹部(Tap)块的报道有限。方法在成人PT患者中比较三种干预措施,包括IV阿片类药物,龙头导管和带有脂质体Bupivacaine的Tap块。记录了肠功能和口服饮食,术后疼痛评分,阿片类药物使用量和逗留时间的时间。结果研究包括197名PT患者:62(32%)标准护理,90(45%)龙头导管,连续0.2%Ropivacaine,45(23%)单脂质体Bupivaine Tap块。 IV阿片类药物组疼痛评分最低(P <0.001)。脂质体Bupivacaine组在术后日(POD)1-5的疼痛评分较低,而不是Tap导管组。对于两个TAP块组(P = 0.03),POD 1-5期间的阿片类药物使用。抽头块组的排便时间更快(P <0.05)。结论与IV阿片类镇痛相比,随着胰腺移植术后,TAP块干预与较低的整体用途和更快的肠功能肠功能有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号